View in EDS HTML Full Text PDF Full Text

Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.

Saved in:
Bibliographic Details
Title: Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.
Authors: Kim YY; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Park H; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Song T; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Choi K; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Dolton M; Genentech Inc, South San Francisco, CA, USA., Mao J; Genentech Inc, South San Francisco, CA, USA., Kim J; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Ahn YG; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Suh KH; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea., Kim YH; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea. yhkeem@hanmi.co.kr.
Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2023 Apr; Vol. 40 (2), pp. 137-148. Date of Electronic Publication: 2023 Feb 10.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36763292
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+YY%22">Kim YY</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Song+T%22">Song T</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Choi+K%22">Choi K</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Dolton+M%22">Dolton M</searchLink>; Genentech Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; Genentech Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+YG%22">Ahn YG</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Suh+KH%22">Suh KH</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YH%22">Kim YH</searchLink>; Hanmi Research Center, Hanmi Pharm. Co. Ltd, Gyeonggi-Do, Korea. yhkeem@hanmi.co.kr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228409970%22">Clinical & experimental metastasis</searchLink> [Clin Exp Metastasis] 2023 Apr; Vol. 40 (2), pp. 137-148. <i>Date of Electronic Publication: </i>2023 Feb 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8409970 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7276 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202620898%22">02620898 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Metastasis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36763292
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10585-023-10198-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 137
    Titles:
      – TitleFull: Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim YY
      – PersonEntity:
          Name:
            NameFull: Park H
      – PersonEntity:
          Name:
            NameFull: Song T
      – PersonEntity:
          Name:
            NameFull: Choi K
      – PersonEntity:
          Name:
            NameFull: Dolton M
      – PersonEntity:
          Name:
            NameFull: Mao J
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Ahn YG
      – PersonEntity:
          Name:
            NameFull: Suh KH
      – PersonEntity:
          Name:
            NameFull: Kim YH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2023 Apr
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7276
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical & experimental metastasis
              Type: main
ResultId 1